Okogen

Developing ophthalmic anti-viral drugs for adenoviral conjunctivitis (pink eye)

placeSan Diego, California, United States calendar_todayFounded 2015 groups3 employees language okogen.com

Innovation

3 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 70 times.

YearFilings
20171
20181
20192
20201
20212
20222
20231
20241

Social engagement

Social engagement: 467 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon